Privately owned Repertoire Immune Medicines announced a partnership worth up to $1.9B with Eli Lilly (LLY) on Thursday to ...

By Christy Santhosh Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies for multiple autoimmune diseases, the ...

Formation Bio and Jiangsu Chia Tai Feng Hai Pharmaceutical Co., LTD. (CTFH) today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to FHND5032, an oral, ...

As part of the deal, Repertoire Immune Medicines will develop up to three drug candidates that target the drivers of certain autoimmune diseases.

Repertoire Immune Medicines partners with Eli Lilly to develop tolerizing therapies for autoimmune diseases, receiving $85 ...

The next major drugmaker interested in what Repertoire has to offer is Eli Lilly, which has thrown down $85 million upfront and floated up to $1.84 billion more in biobucks to collaborate on potential ...

Dr. Lacy Anderson says Sjogren’s syndrome is frequently linked to other autoimmune diseases and may also affect the digestive ...

Explore the vital role of bone marrow stem cells. Learn how they drive bone remodeling, immunity, and skeletal health in this ...

Autoimmune neurological diseases are conditions where the immune system attacks nerve cells. Damage to neuronal cells can lead to a variety of neurologic and psychiatric symptoms. Autoimmune diseases ...

Southeast Alabama experienced a rollercoaster of weather events in a single week, creating additional challenges for residents managing chronic health conditions.

A relatively new class of autoimmune diseases that affect the brain is making psychiatrists rethink some diagnoses.

Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies for multiple autoimmune diseases, the Massachusetts-based ...